An article published is yesterday's edition of The Globe and Mail:
By Anne McIlroy
A Canadian psychiatric hospital will be the first in the world to use a combination of genetic testing and brain imaging to help determine the best course of treatment for patients with schizophrenia, depression, bipolar disorder and other mental illnesses.A few dozen patients will take part starting in the fall, and the experimental program will slowly ramp up to include 100 people, says James Kennedy, director of the neuroscience research department at the Centre for Addiction and Mental Health in Toronto. If it proves successful, the program will be a step toward giving psychiatrists more precise tools to assess patients with common psychiatric conditions.
“It is a small revolution, a great opportunity to change, in a fundamental way, how we treat patients,” says Dr. Kennedy, who along with his colleague, Sylvain Houle, is leading the new research initiative.
To read the entire article, please click here.
Also see:
CAMH combines genetics with brain imaging to personalize treatment for mental illness and addictions
I thank John Devlin for bringing this article to my attention.
